KENNEDY THOMAS P has a total of 15 patent applications. Its first patent ever was published in 1984. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals, macromolecular chemistry and polymers and organic fine chemistry are BIOSPHINGS AG, ORPHAN MEDICAL INC and BIOSUCCESS BIOTECH CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Australia | 2 | |
#4 | Canada | 2 | |
#5 | United States | 2 | |
#6 | Italy | 1 | |
#7 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Macromolecular chemistry and polymers | |
#3 | Organic fine chemistry | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Polysaccharides | |
#4 | Unspecified technologies | |
#5 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Kennedy Thomas P | 15 |
#2 | Hoidal John R | 1 |
Publication | Filing date | Title |
---|---|---|
JP2005232191A | Method and drug for inhibiting neutrophil elastase and cathepsin g | |
AU1742695A | Production and use of 2-o-desulfated heparin to inhibit elastase | |
EP1164145A2 | Non-anticoagulant desulfated heparins as medicaments | |
WO9115216A1 | Method and medicament for prevention or medication of human leucocyte elastase-mediated pulmonary diseases | |
WO8502174A1 | Pharmacological applications of diphenylhalonium ion | |
US4623666A | Pharmacological applications of diphenylhalonium ion | |
IT8449122D0 | Pharmacological use of di:phenyl-iodonium cpds. |